CLINICAL_TRIALS
trial_result
· 2021-10-06
Clinical Trial Update: Subcutaneous Methylnaltrexone Versus Placebo for Postoperative Ileus Prevention [Phase 2]
Summary
Phase 2 trial comparing subcutaneous methylnaltrexone to placebo for prevention of postoperative ileus has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ohio State University | Conditions: Postoperative Ileus | Phase 2 | Status: COMPLETED | Results posted: 2021-10-06